Epizyme, Inc. (EPZM)

Stock Performance

Last:

16.1500

Change:

-0.3500

3 Month Stock History Chart

HQ Location

400 Technology Square 4th Floor
Cambridge, MA 2139

Company Description

Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression.